Wearable and Patient-reported Outcome-based Continuous Assessment and Support Alerts in Palliative Care
NCT ID: NCT05273580
Last Updated: 2023-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2021-04-15
2021-11-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Wearable Device to Improve Quality of Palliative Care
NCT05054907
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
NCT07058064
Telematics Device for Daily Monitoring of Vital Signs in Cancer
NCT05650814
Smart Home Care of Cloud Base ECG on the Cardiotoxicity Prevention on the Cancer Patients.
NCT04885088
Digital Smartwatch Measurements as Potential Biomarkers for Remote Disease Tracking in ALS
NCT05830214
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Throughout the study, wearable sensors are used to passively record physiological data from patient/carer dyads. During wear times, WS recordings trigger ecological momentary assessments (EMAs) conducted via surveys. This pilot investigates the feasibility and acceptability of EMAs in community palliative care and the potential for incorporating EMA-based interventions into routine care. Future studies may explore the possibility of ecological momentary interventions (EMIs) to trigger just-in-time targeted interventions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Eligible patients will be identified by the Nurse Practitioner Cancer \& Palliative Care.
Garmin VivoSmart 4
Wearable sensor to record; sleep, stress, heart rate etc.
mema - ilumivu
mEMA is the a self-service platform running on both iOS and Android that is specifically designed for the administration of mobile Ecological Momentary Assessment or Experience Sampling research studies.
Carers
The respective carers who are identified by the Nurse Practitioner Cancer \& Palliative Care as eligible participants.
Garmin VivoSmart 4
Wearable sensor to record; sleep, stress, heart rate etc.
mema - ilumivu
mEMA is the a self-service platform running on both iOS and Android that is specifically designed for the administration of mobile Ecological Momentary Assessment or Experience Sampling research studies.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Garmin VivoSmart 4
Wearable sensor to record; sleep, stress, heart rate etc.
mema - ilumivu
mEMA is the a self-service platform running on both iOS and Android that is specifically designed for the administration of mobile Ecological Momentary Assessment or Experience Sampling research studies.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient and carer dyad
* Both patient and carer consent
* Patient Karnofsky Performance Scale ≥ 50
* Patient and carer have compatible smart phone
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Royal North Shore Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thilo Schuler
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thilo Schuler
Role: PRINCIPAL_INVESTIGATOR
Royal North Shore Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal North Shore Hospital
St Leonards, New South Wales, Australia
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Project website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
wePRO-CASA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.